{
    "q": [
        {
            "docid": "270990_11",
            "document": "DNA methyltransferase . DNMT1 is the most abundant DNA methyltransferase in mammalian cells, and considered to be the key maintenance methyltransferase in mammals. It predominantly methylates hemimethylated CpG di-nucleotides in the mammalian genome. This enzyme is 7\u2013 to 100-fold more active on hemimethylated DNA as compared with unmethylated substrate \"in vitro\", but it is still more active at \"de novo\" methylation than other DNMTs. The recognition motif for the human enzyme involves only three of the bases in the CpG dinucleotide pair: a C on one strand and CpG on the other. This relaxed substrate specificity requirement allows it to methylate unusual structures like DNA slippage intermediates at de novo rates that equal its maintenance rate. Like other DNA cytosine-5 methyltransferases the human enzyme recognizes flipped out cytosines in double stranded DNA and operates by the nucleophilic attack mechanism. In human cancer cells DNMT1 is responsible for both \"de novo\" and maintenance methylation of tumor suppressor genes. The enzyme is about 1,620 amino acids long. The first 1,100 amino acids constitute the regulatory domain of the enzyme, and the remaining residues constitute the catalytic domain. These are joined by Gly-Lys repeats. Both domains are required for the catalytic function of DNMT1.",
            "score": 315.6661067008972
        },
        {
            "docid": "1137227_35",
            "document": "DNA methylation . The principal \"Arabidopsis\" DNA methyltransferase enzymes, which transfer and covalently attach methyl groups onto DNA, are DRM2, MET1, and CMT3. Both the DRM2 and MET1 proteins share significant homology to the mammalian methyltransferases DNMT3 and DNMT1, respectively, whereas the CMT3 protein is unique to the plant kingdom. There are currently two classes of DNA methyltransferases: 1) the \"de novo\" class, or enzymes that create new methylation marks on the DNA; and 2) a maintenance class that recognizes the methylation marks on the parental strand of DNA and transfers new methylation to the daughters strands after DNA replication. DRM2 is the only enzyme that has been implicated as a \"de novo\" DNA methyltransferase. DRM2 has also been shown, along with MET1 and CMT3 to be involved in maintaining methylation marks through DNA replication. Other DNA methyltransferases are expressed in plants but have no known function (see the Chromatin Database).",
            "score": 260.100194811821
        },
        {
            "docid": "53493192_3",
            "document": "GLAD-PCR assay . Method was specially designed to determine methylation of RCGY site of interest in human and mammalian genomes in excess of corresponding unmethylated sites. This is a typical situation for DNA preparations from clinical samples of blood and tissues. GLAD-PCR assay is based on the new type of enzymes - site-specific methyl-directed DNA-endonucleases (MD DNA endonucleases). These enzymes are very similar to restriction enzymes in biochemical properties and cleave DNA completely, but act in opposite way: they cleave only methylated DNA and do not cleave unmethylated DNA at all. Mammalian DNA-methyltransferases DNMT1, DNMT3a and DNMT3b catalyze a reaction of DNA methylation. It is well known that hypermethylation of CpG-islands in regulatory regions of promoter and/or first exon in a variety of genes often occurs at early stages of sporadic carcinogenesis. This leads to downregulation of the genes expression in tumor cells, whereas in a healthy tissue the corresponding genes remain to be active. Thus, the detection of such epigenetic biomarkers is one of the most promising diagnostic and prognostic tools Study of DNMT3a and DNMT3b substrate specificity has shown that both enzymes predominantly recognize RCGY site and modify internal CG-dinucleotide to form 5\u2019-R(5mC)GY-3\u2019/3\u2019-YG(5mC) R-5\u2019 sequence. One of new enzymes GlaI recognizes and cleaves site R(5mC)GY. Due to this unique substrate specificity, GlaI is a convenient tool for identification of \"de novo\" methylated sites in the human and mammalian DNA.GLAD-PCR assay includes 3 simple steps:  Assay is performed in one tube, takes about 2\u20133 hours and determines even several copies of DNA with R(5mC)GY site of interest.",
            "score": 295.2757736444473
        },
        {
            "docid": "9458453_2",
            "document": "DNMT1 . DNA (cytosine-5)-methyltransferase 1 is an enzyme that catalyzes the transfer of methyl groups to specific CpG structures in DNA, a process called DNA methylation. In humans, it is encoded by the \"DNMT1\" gene. DNMT1 forms part of the family of DNA methyltransferase enzymes, which consists primarily of DNMT1, DNMT3A, and DNMT3B.",
            "score": 330.88458728790283
        },
        {
            "docid": "39981969_18",
            "document": "Hereditary sensory and autonomic neuropathy type I . HSAN IE is associated with heterozygous missense mutations in the \"DNMT1\" gene which encodes DNA methyltransferase 1 (Dnmt1). Dnmt1 belongs to a family of enzymes that catalyze the transfer of a methyl group from \"S\"-adenosyl methionine to DNA. Dnmt1 has a high preference for hemimethylated DNA, hence it is called maintenance methyltransferase. The protein also has \"de novo\" DNA methyltransferase activity which is responsible for establishing methylation patterns during embryonic development. Dnmt1 is highly expressed in post-mitotic neurons in the adult central nervous system, with peak expression during the S-phase of the cell cycle.",
            "score": 335.67752397060394
        },
        {
            "docid": "57388876_9",
            "document": "Epigenetics of anxiety and stress-related disorders . DNA methyltransferase 1 (DNMT1) belongs to a family of proteins known as DNA methyltransferases, which are enzymes that add methyl groups to DNA. DNMT1 is specifically involved in maintaining DNA methylation; hence it is also known as the maintenance methylase DNMT1. DNMT1 aids in regulation of gene expression by methylating promoter regions of genes, causing transcriptional repression of these genes.",
            "score": 307.76670145988464
        },
        {
            "docid": "14170781_3",
            "document": "DNA (cytosine-5)-methyltransferase 3A . This enzyme is responsible for \"de novo\" DNA methylation. Such function is to be distinguished from maintenance DNA methylation which ensures the fidelity of replication of inherited epigenetic patterns. DNMT3A forms part of the family of DNA methyltransferase enzymes, which consists of the protagonists DNMT1, DNMT3A and DNMT3B.",
            "score": 288.8123240470886
        },
        {
            "docid": "49033_25",
            "document": "Epigenetics . Mechanisms of heritability of histone state are not well understood; however, much is known about the mechanism of heritability of DNA methylation state during cell division and differentiation. Heritability of methylation state depends on certain enzymes (such as DNMT1) that have a higher affinity for 5-methylcytosine than for cytosine. If this enzyme reaches a \"hemimethylated\" portion of DNA (where 5-methylcytosine is in only one of the two DNA strands) the enzyme will methylate the other half.",
            "score": 259.43803668022156
        },
        {
            "docid": "26194_14",
            "document": "Restriction enzyme . Type I restriction enzymes were the first to be identified and were first identified in two different strains (K-12 and B) of \"E. coli\". These enzymes cut at a site that differs, and is a random distance (at least 1000 bp) away, from their recognition site. Cleavage at these random sites follows a process of DNA translocation, which shows that these enzymes are also molecular motors. The recognition site is asymmetrical and is composed of two specific portions\u2014one containing 3\u20134 nucleotides, and another containing 4\u20135 nucleotides\u2014separated by a non-specific spacer of about 6\u20138 nucleotides. These enzymes are multifunctional and are capable of both restriction and modification activities, depending upon the methylation status of the target DNA. The cofactors S-Adenosyl methionine (AdoMet), hydrolyzed adenosine triphosphate (ATP), and magnesium (Mg) ions, are required for their full activity. Type I restriction enzymes possess three subunits called HsdR, HsdM, and HsdS; HsdR is required for restriction; HsdM is necessary for adding methyl groups to host DNA (methyltransferase activity), and HsdS is important for specificity of the recognition (DNA-binding) site in addition to both restriction (DNA cleavage) and modification (DNA methyltransferase) activity.",
            "score": 188.92746210098267
        },
        {
            "docid": "37214939_13",
            "document": "History of genetic engineering . In 1972 Paul Berg used restriction enzymes and DNA ligases to create the first recombinant DNA molecules. He combined DNA from the monkey virus SV40 with that of the lambda virus. Herbert Boyer and Stanley Norman Cohen took Berg's work a step further and introduced recombinant DNA into a bacterial cell. Cohen was researching plasmids, while Boyers work involved restriction enzymes. They recognised the complementary nature of their work and teamed up in 1972. Together they found a restriction enzyme that cut the pSC101 plasmid at a single point and were able to insert and ligate a gene that conferred resistance to the kanamycin antibiotic into the gap. Cohen had previously devised a method where bacteria could be induced to take up a plasmid and using this they were able to create a bacteria that survived in the presence of the kanamycin. This represented the first genetically modified organism. They repeated experiments showing that other genes could be expressed in bacteria, including one from the toad Xenopus laevis, the first cross kingdom transformation. In 1974 Rudolf Jaenisch created a transgenic mouse by introducing foreign DNA into its embryo, making it the world\u2019s first transgenic animal. Jaenisch was studying mammalian cells infected with simian virus 40 (SV40) when he happened to read a paper from Beatrice Mintz describing the generation of chimera mice. He took his SV40 samples to Mintz's lab and injected them into early mouse embryos expecting tumours to develop. The mice appeared normal, but after using radioactive probes he discovered that the virus had integrated itself into the mice genome. However the mice did not pass the transgene to their offspring. In 1981 the laboratories of Frank Ruddle, Frank Constantini and Elizabeth Lacy injected purified DNA into a single-cell mouse embryo and showed transmission of the genetic material to subsequent generations.",
            "score": 207.60994291305542
        },
        {
            "docid": "496312_4",
            "document": "Nuclease . In the late 1960s, scientists Stuart Linn and Werner Arber isolated examples of the two types of enzymes responsible for phage growth restriction in Escherichia coli (E. coli) bacteria. One of these enzymes added a methyl group to the DNA, generating methylated DNA, while the other cleaved unmethylated DNA at a wide variety of locations along the length of the molecule. The first type of enzyme was called a \"methylase\" and the other a \"restriction nuclease\". These enzymatic tools were important to scientists who were gathering the tools needed to \"cut and paste\" DNA molecules. What was then needed was a tool that would cut DNA at specific sites, rather than at random sites along the length of the molecule, so that scientists could cut DNA molecules in a predictable and reproducible way.",
            "score": 175.421804189682
        },
        {
            "docid": "26194_17",
            "document": "Restriction enzyme . Type III restriction enzymes (e.g., EcoP15) recognize two separate non-palindromic sequences that are inversely oriented. They cut DNA about 20\u201330 base pairs after the recognition site. These enzymes contain more than one subunit and require AdoMet and ATP cofactors for their roles in DNA methylation and restriction, respectively. They are components of prokaryotic DNA restriction-modification mechanisms that protect the organism against invading foreign DNA. Type III enzymes are hetero-oligomeric, multifunctional proteins composed of two subunits, Res and Mod. The Mod subunit recognises the DNA sequence specific for the system and is a modification methyltransferase; as such, it is functionally equivalent to the M and S subunits of type I restriction endonuclease. Res is required for restriction, although it has no enzymatic activity on its own. Type III enzymes recognise short 5\u20136 bp-long asymmetric DNA sequences and cleave 25\u201327 bp downstream to leave short, single-stranded 5' protrusions. They require the presence of two inversely oriented unmethylated recognition sites for restriction to occur. These enzymes methylate only one strand of the DNA, at the N-6 position of adenosyl residues, so newly replicated DNA will have only one strand methylated, which is sufficient to protect against restriction. Type III enzymes belong to the beta-subfamily of N6 adenine methyltransferases, containing the nine motifs that characterise this family, including motif I, the AdoMet binding pocket (FXGXG), and motif IV, the catalytic region (S/D/N (PP) Y/F).",
            "score": 175.29287719726562
        },
        {
            "docid": "14170781_8",
            "document": "DNA (cytosine-5)-methyltransferase 3A . DNMT1 is responsible for maintenance DNA methylation while DNMT3A and DNMT3B carry out both maintenance \u2013 correcting the errors of DNMT1 \u2013 and de novo DNA methylation. After DNMT1 knockout in human cancer cells, these cells were found to retain their inherited methylation pattern, which suggests maintenance activity by the expressed DNMT3s. DNMT3s show equal affinity for unmethylated and hemimethylated DNA substrates while DNMT1 has a 10-40 fold preference for hemimethylated DNA. The DNMT3s can bind to both forms and hence potentially do both maintenance and de novo modifications.",
            "score": 354.6841731071472
        },
        {
            "docid": "49547293_9",
            "document": "Thymidine kinase in clinical chemistry . Thymidine monophosphate, the product of the reaction catalyzed by thymidine kinase, is in turn phosphorylated to thymidine diphosphate by the enzyme thymidylate kinase and further to thymidine triphosphate by the enzyme nucleoside diphosphate kinase. The triphosphate is included in a DNA molecule, a reaction catalyzed by a DNA polymerase and a complementary DNA molecule (or an RNA molecule in the case of reverse transcriptase, an enzyme present in retrovirus). Thymidine monophosphate is produced by the cell in two different reactions - either by phosphorylation of thymidine as described above or by methylation of deoxyuridine monophosphate, a product of other metabolic pathways unrelated to thymidine, by the enzyme thymidylate synthase. The second route is used by the cell under normal conditions, and it is sufficient to supply thymidine monophosphate for DNA repair. When a cell prepares to divide, a complete new set-up of DNA is required, and the requirement for building blocks, including thymidine triphosphate, increases. Cells prepare for cell division by making some of the enzymes required during the division. They are not normally present in the cells and are downregulated and degraded afterwards. Such enzymes are called salvage enzymes. Thymidine kinase 1 is such a salvage enzyme, whereas thymidine kinase 2 is not cell cycle-dependent.",
            "score": 219.64675450325012
        },
        {
            "docid": "5065725_11",
            "document": "Methyltransferase . DNA methylation, a key component of genetic regulation, occurs primarily at the 5-carbon of the base cytosine, forming 5\u2019methylcytosine (see left). Methylation is an epigenetic modification catalyzed by DNA methyltransferase enzymes, including DNMT1, DNMT2, and DNMT3. These enzymes use S-adenosylmethionine as a methyl donor and contain several highly conserved structural features between the three forms; these include the S-adenosylmethionine binding site, a vicinal proline-cysteine pair which forms a thiolate anion important for the reaction mechanism, and the cytosine substrate binding pocket. Many features of DNA methyltransferases are highly conserved throughout many classes of life, from bacteria to mammals. In addition to controlling the expression of certain genes, there are a variety of protein complexes, many with implications for human health, which only bind to methylated DNA recognition sites. Many of the early DNA methyltransferases have been thought to be derived from RNA methyltransferases that were supposed to be active in the RNA world to protect many species of primitive RNA. RNA methylation has been observed in different types of RNA species viz.mRNA, rRNA, tRNA, snoRNA, snRNA, miRNA, tmRNA as well as viral RNA species. Specific RNA methyltransferases are employed by cells to mark these on the RNA species according to the need and environment prevailing around the cells, which form a part of field called molecular epigenetics. 2'-O-methylation, m6A methylation, m1G methylation as well as m5C are most commonly methylation marks observed in different types of RNA.",
            "score": 289.3173792362213
        },
        {
            "docid": "253418_25",
            "document": "DNA computing . Enzyme based DNA computers are usually of the form of a simple Turing machine; there is analogous hardware, in the form of an enzyme, and software, in the form of DNA. Benenson, Shapiro and colleagues have demonstrated a DNA computer using the FokI enzyme and expanded on their work by going on to show automata that diagnose and react to prostate cancer: under expression of the genes PPAP2B and GSTP1 and an over expression of PIM1 and HPN. Their automata evaluated the expression of each gene, one gene at a time, and on positive diagnosis then released a single strand DNA molecule (ssDNA) that is an antisense for MDM2. MDM2 is a repressor of protein 53, which itself is a tumor suppressor. On negative diagnosis it was decided to release a suppressor of the positive diagnosis drug instead of doing nothing. A limitation of this implementation is that two separate automata are required, one to administer each drug. The entire process of evaluation until drug release took around an hour to complete. This method also requires transition molecules as well as the FokI enzyme to be present. The requirement for the FokI enzyme limits application \"in vivo\", at least for use in \"cells of higher organisms\". It should also be pointed out that the 'software' molecules can be reused in this case.",
            "score": 171.46297335624695
        },
        {
            "docid": "3570811_2",
            "document": "Werner syndrome helicase . \"Werner syndrome ATP-dependent helicase\" also known as DNA helicase, RecQ-like type 3 is an enzyme that in humans is encoded by the WRN gene. WRN is a member of the RecQ Helicase family. Helicase enzymes generally unwind and separate double-stranded DNA. These activities are necessary before DNA can be copied in preparation for cell division (DNA replication). Helicase enzymes are also critical for making a blueprint of a gene for protein production, a process called transcription. Further evidence suggests that Werner protein plays a critical role in repairing DNA. Overall, this protein helps maintain the structure and integrity of a person's DNA.",
            "score": 197.5671763420105
        },
        {
            "docid": "50312204_2",
            "document": "HpaII . HpaII (IntEnz: \"EC 3.1.21.4\") is a restriction enzyme obtained from the microorganism called Haemophilus parainfluenzae. It is a DNA restriction enzyme, therefore it has the ability to cut the DNA from certain region as demonstrated below. It has the ability to produce cohesive ends, which are rather useful in constructing plasmids. HpaII will not cut sites that have been methylated by SssI methyltransferase or HpaII methyltransferase. When the sites have been methylated by MspI methyltransferase, the enzyme will cut 300 times slower than unmethylated DNA and 50 times slower if the DNA is hemi-methylated. This feature is exploited for determination of the clonal origin of a mammalian female tumor through HUMARA assay.",
            "score": 184.0491874217987
        },
        {
            "docid": "50274456_12",
            "document": "HUMARA assay . In order to make a conclusion about the clonality of a tumor, it is best to use the DNA from a normal tissue of the same person, and a sample without enzyme treatment must also be amplified as a control. If, even in normal tissues without enzyme treatment, a single band is observed, it may be explained as follows; this person has the genetic pattern as XO (this possibility can be excluded to see a band after enzyme treatment because, if indeed XO is the genetic pattern of the sample, then, there will be NO methylation, therefore no band should be visible after digesting with the enzyme. In the case of seeing a band after enzyme treatment, the observation is most likely to mean that the person has two X chromosomes with exact CAG repeats.) When you see two bands for normal tissue (both enzyme treated and untreated), and you see two bands for enzyme treated tumor sample but two bands for untreated tumor DNA, then you are surely looking at a polyclonal tumor. However, if you see the same number of bands only with a single band after enzyme treatment, there is a rather high chance for the tumor of your interest to be monoclonal. In this last case, monoclonality is not for sure because, as stated earlier, there is the possibility of having exact same -CAG- repeats on both alleles.",
            "score": 144.8921718597412
        },
        {
            "docid": "1301827_7",
            "document": "Last universal common ancestor . The genetic code was most likely based on DNA. Some studies suggest that LUCA may have lacked DNA and been defined wholly through RNA. If DNA was present, it was composed of four nucleotides (deoxyadenosine, deoxycytidine, deoxythymidine, and deoxyguanosine), to the exclusion of other possible deoxynucleotides. The DNA was kept double-stranded by a template-dependent enzyme, DNA polymerase. The integrity of the DNA was maintained by a group of maintenance enzymes, including DNA topoisomerase, DNA ligase and other DNA repair enzymes. The DNA was also protected by DNA-binding proteins such as histones. The genetic code was composed of three-nucleotide codons, thus producing 64 different codons. Since only 20 amino acids were used, multiple codons code for the same amino acids. If the code was DNA-based, it operated as follows. The genetic code was expressed via RNA intermediates, which were single-stranded. The RNA was produced by a DNA-dependent RNA polymerase using nucleotides similar to those of DNA, with the exception that the nucleotide thymidine in DNA was replaced by uridine in RNA.",
            "score": 141.21471238136292
        },
        {
            "docid": "14170781_2",
            "document": "DNA (cytosine-5)-methyltransferase 3A . DNA (cytosine-5)-methyltransferase 3A is an enzyme that catalyzes the transfer of methyl groups to specific CpG structures in DNA, a process called DNA methylation. The enzyme is encoded in humans by the DNMT3A gene.",
            "score": 213.57293248176575
        },
        {
            "docid": "3322454_13",
            "document": "Glyoxylate cycle . In order to engineer the pathway into cells, the genes responsible for coding for the enzymes had to be isolated and sequenced, which was done using the bacteria \"E.coli\", from which the AceA gene, responsible for encoding for isocitrate lyase, and the AceB gene, responsible for encoding for malate synthase were sequenced. Engineers have been able to successfully incorporate the AceA and AceB genes into mammalian cells in culture, and the cells were successful in translating and transcribing the genes into the appropriate enzymes, proving that the genes could successfully be incorporated into the cell\u2019s DNA without damaging the functionality or health of the cell. However, being able to engineer the pathway into transgenic mice has proven to be difficult for engineers. While the DNA has been expressed in some tissues, including the liver and small intestine in test animals, the level of expression is not high, and not found to be statistically significant. In order to successfully engineer the pathway, engineers would have to fuse the gene with promoters which could be regulated in order to increase the level of expression, and have the expression in the right cells, such as epithelial cells.",
            "score": 234.52852082252502
        },
        {
            "docid": "7955_58",
            "document": "DNA . Topoisomerases are enzymes with both nuclease and ligase activity. These proteins change the amount of supercoiling in DNA. Some of these enzymes work by cutting the DNA helix and allowing one section to rotate, thereby reducing its level of supercoiling; the enzyme then seals the DNA break. Other types of these enzymes are capable of cutting one DNA helix and then passing a second strand of DNA through this break, before rejoining the helix. Topoisomerases are required for many processes involving DNA, such as DNA replication and transcription.",
            "score": 129.6927788257599
        },
        {
            "docid": "35868491_13",
            "document": "Epigenetics in stem-cell differentiation . In mammals, DNA methylation plays a role in regulating a key component of multipotency\u2014the ability to rapidly self-renew. Khavari et al. discussed the fundamental mechanisms of DNA methylation and the interaction with several pathways regulating differentiation. New approaches studying the genomic status of DNA methylation in various states of differentiation have shown that methylation at CpG sites associated with putative enhancers are important in this process. DNA methylation can modulate the binding affinities of transcription factors by recruiting repressors such as \"MeCP2\" which display binding specificity for sequences containing methylated CpG dinucleotides. DNA methylation is controlled by certain methyltransferases, \"DMNTs\", which perform different functions depending on each one. \"DNMT3A\" and \"DNMT3B\" have both been linked to a role in the establishment of DNA methylation pattern in the early development of the stem cell, whereas \"DNMT1\" is required to methylate a newly synthesized strand of DNA after the cell has undergone replication in order to sustain the epigenetic regulatory state. Numerous proteins can physically interact with \"DNMTs\" themselves, which help target \"DNMT1\" to hemi-methylated DNA.",
            "score": 334.53623509407043
        },
        {
            "docid": "270990_4",
            "document": "DNA methyltransferase . m6A and m4C methyltransferases are found primarily in prokaryotes. m5C methyltransfereases are found in some lower eukaryotes, in most higher plants, and in animals beginning with the echinoderms. The m6A methyltransferases (N-6 adenine-specific DNA methylase) (A-Mtase) are enzymes that specifically methylate the amino group at the C-6 position of adenines in DNA. They are found in the three existing types of bacterial restriction-modification systems (in type I system the A-Mtase is the product of the hsdM gene, and in type III it is the product of the mod gene). These enzymes are responsible for the methylation of specific DNA sequences in order to prevent the host from digesting its own genome via its restriction enzymes. These methylases have the same sequence specificity as their corresponding restriction enzymes. These enzymes contain a conserved motif Asp/Asn-Pro-Pro-Tyr/Phe in their N-terminal section, this conserved region could be involved in substrate binding or in the catalytic activity. The structure of N6-MTase TaqI (M.TaqI) has been resolved to 2.4 A. The molecule folds into 2 domains, an N-terminal catalytic domain, which contains the catalytic and cofactor binding sites, and comprises a central 9-stranded beta-sheet, surrounded by 5 helices; and a C-terminal DNA recognition domain, which is formed by 4 small beta-sheets and 8 alpha-helices. The N- and C-terminal domains form a cleft that accommodates the DNA substrate. A classification of N-MTases has been proposed, based on conserved motif (CM) arrangements. According to this classification, N6-MTases that have a DPPY motif (CM II) occurring after the FxGxG motif (CM I) are designated D12 class N6-adenine MTases. The type I restriction and modification system is composed of three polypeptides R, M and S. The M (hsdM) and S subunits together form a methyltransferase that methylates two adenine residues in complementary strands of a bipartite DNA recognition sequence. In the presence of the R subunit, the complex can also act as an endonuclease, binding to the same target sequence but cutting the DNA some distance from this site. Whether the DNA is cut or modified depends on the methylation state of the target sequence. When the target site is unmodified, the DNA is cut. When the target site is hemimethylated, the complex acts as a maintenance methyltransferase, modifying the DNA so that both strands become methylated. hsdM contains an alpha-helical domain at the N-terminus, the HsdM N-terminal domain.",
            "score": 212.38361144065857
        },
        {
            "docid": "34217148_5",
            "document": "Vectors in gene therapy . The genetic material in retroviruses is in the form of RNA molecules, while the genetic material of their hosts is in the form of DNA. When a retrovirus infects a host cell, it will introduce its RNA together with some enzymes, namely reverse transcriptase and integrase, into the cell. This RNA molecule from the retrovirus must produce a DNA copy from its RNA molecule before it can be integrated into the genetic material of the host cell. The process of producing a DNA copy from an RNA molecule is termed reverse transcription. It is carried out by one of the enzymes carried in the virus, called reverse transcriptase. After this DNA copy is produced and is free in the nucleus of the host cell, it must be incorporated into the genome of the host cell. That is, it must be inserted into the large DNA molecules in the cell (the chromosomes). This process is done by another enzyme carried in the virus called integrase.",
            "score": 200.12956428527832
        },
        {
            "docid": "17062920_39",
            "document": "DNA damage theory of aging . Several reviews summarize evidence that the methylation enzyme DNMT1 is recruited to sites of oxidative DNA damage. Recruitment of DNMT1 leads to DNA methylation at the promoters of genes to inhibit transcription during repair. In addition, the 2018 review describes recruitment of DNMT1 during repair of DNA double-strand breaks. DNMT1 localization results in increased DNA methylation near the site of recombinational repair, associated with altered expression of the repaired gene. In general, repair-associated hyper-methylated promoters are restored to their former methylation level after DNA repair is complete. However, these reviews also indicate that transient recruitment of epigenetic modifiers can occasionally result in subsequent stable epigenetic alterations and gene silencing after DNA repair has been completed.",
            "score": 272.05124938488007
        },
        {
            "docid": "37690706_15",
            "document": "Epigenetics of schizophrenia . Epigenetics (translated as \"above genetics\") is the study of how genes are regulated through reversible and heritable molecular mechanisms. The epigenetic changes modify gene expression through either activation of the gene that codes for a certain protein, or repression of the gene. There are two main categories of modifications: the methylation of DNA and modifications to histones. Research findings have demonstrated that several examples of both of these changes are linked to schizophrenia and its symptoms. DNA methylation is the covalent addition of a methyl group to a segment of the DNA code. These -CH3 groups are added to cytosine residues by the DNMT (DNA Methytransferases) enzymes. The binding methyl group to promoter regions interferes with the binding of transcription factors and silences the gene by preventing the transcription of that code. DNA methylation is one of the most well studied epigenetic mechanisms and there have been several findings linking it to schizophrenia.",
            "score": 240.76408433914185
        },
        {
            "docid": "339894_2",
            "document": "Histone methyltransferase . Histone methyltransferases (HMT) are histone-modifying enzymes (e.g., histone-lysine N-methyltransferases and histone-arginine N-methyltransferases), that catalyze the transfer of one, two, or three methyl groups to lysine and arginine residues of histone proteins. The attachment of methyl groups occurs predominantly at specific lysine or arginine residues on histones H3 and H4. Two major types of histone methyltranferases exist, lysine-specific (which can be SET (Su(var)3-9, Enhancer of Zeste, Trithorax) domain containing or non-SET domain containing) and arginine-specific. In both types of histone methyltransferases, cofactor S-Adenosyl methionine (SAM) serves as a cofactor and methyl donor group. In eukaryotic cells, the genome is tightly condensed into chromatin (composed of DNA and histone proteins), so enzymes, such as histone methyltransferases, must overcome this inaccessibility. Histone methyltransferase does so by modifying histones at certain sites through methylation. Methylation of histones is important biologically because it is the principal epigenetic modification of chromatin that determines gene expression, genomic stability, stem cell maturation, cell lineage development, genetic imprinting, DNA methylation, and cell mitosis.",
            "score": 242.33690321445465
        },
        {
            "docid": "14334314_4",
            "document": "DNA-(apurinic or apyrimidinic site) lyase . Since DNA AP lyase is a class of structures who have numerous target genes that encode for different variations of the enzyme, there is no one single enzyme structure that can be used as an example that encompasses all versions of the enzyme. As of March 2015, 99 structures have been solved for this class of enzymes, including 23 PDB accession codes , , , , , , , , , , , , , , , , , , , , , , and . APE1 is a gene that codes for DNA AP lyase in humans which binds to AP DNA loops into both the DNA major and minor grooves and binds a flipped-out AP site in a pocket that excludes DNA bases and racemized-anomer AP sites. Both the APE1 active-site geometry and a complex with cleaved AP-DNA and Mn support a testable structure-based catalytic mechanism. Mn stabilizes the reaction of the lyase activity.",
            "score": 145.73763835430145
        },
        {
            "docid": "17062920_21",
            "document": "DNA damage theory of aging . One variation of the idea that mutation is the basis of aging, that has received much attention, is that mutations specifically in mitochondrial DNA are the cause of aging. Several studies have shown that mutations accumulate in mitochondrial DNA in infrequently replicating cells with age. DNA polymerase gamma is the enzyme that replicates mitochondrial DNA. A mouse mutant with a defect in this DNA polymerase is only able to replicate its mitochondrial DNA inaccurately, so that the mutation rate is 500-fold higher than in normal mice. These mice showed no clear features of rapidly accelerated aging (Trifunovic et al., 2004.). Overall, the observations discussed in this section indicate that mutations are not the primary cause of aging.",
            "score": 176.6647698879242
        },
        {
            "docid": "57386068_6",
            "document": "Epigenetic effects of smoking . Chemicals in smoke can damage DNA, which subsequently leads to changes in DNA methylation during the repair process. Damage typically comes in the form of double-strand breaks that are linked to carcinogens like arsenic, chromium, formaldehyde, polycyclic aromatic hydrocarbons, and nitrosamines which are found in cigarette smoke. DNMT1 is the enzyme involved in the maintenance of DNA methylation marks. DNMT1 is recruited to DNA during its replication, or during DNA repair. As a new DNA strand is synthesized, unmethylated cytosines are incorporated into the sequence. This leads to hemimethylated DNA, where an older methylated strand is bound to a younger unmethylated one.",
            "score": 249.27553939819336
        }
    ],
    "r": [
        {
            "docid": "14170781_8",
            "document": "DNA (cytosine-5)-methyltransferase 3A . DNMT1 is responsible for maintenance DNA methylation while DNMT3A and DNMT3B carry out both maintenance \u2013 correcting the errors of DNMT1 \u2013 and de novo DNA methylation. After DNMT1 knockout in human cancer cells, these cells were found to retain their inherited methylation pattern, which suggests maintenance activity by the expressed DNMT3s. DNMT3s show equal affinity for unmethylated and hemimethylated DNA substrates while DNMT1 has a 10-40 fold preference for hemimethylated DNA. The DNMT3s can bind to both forms and hence potentially do both maintenance and de novo modifications.",
            "score": 354.6841735839844
        },
        {
            "docid": "39981969_18",
            "document": "Hereditary sensory and autonomic neuropathy type I . HSAN IE is associated with heterozygous missense mutations in the \"DNMT1\" gene which encodes DNA methyltransferase 1 (Dnmt1). Dnmt1 belongs to a family of enzymes that catalyze the transfer of a methyl group from \"S\"-adenosyl methionine to DNA. Dnmt1 has a high preference for hemimethylated DNA, hence it is called maintenance methyltransferase. The protein also has \"de novo\" DNA methyltransferase activity which is responsible for establishing methylation patterns during embryonic development. Dnmt1 is highly expressed in post-mitotic neurons in the adult central nervous system, with peak expression during the S-phase of the cell cycle.",
            "score": 335.6775207519531
        },
        {
            "docid": "35868491_13",
            "document": "Epigenetics in stem-cell differentiation . In mammals, DNA methylation plays a role in regulating a key component of multipotency\u2014the ability to rapidly self-renew. Khavari et al. discussed the fundamental mechanisms of DNA methylation and the interaction with several pathways regulating differentiation. New approaches studying the genomic status of DNA methylation in various states of differentiation have shown that methylation at CpG sites associated with putative enhancers are important in this process. DNA methylation can modulate the binding affinities of transcription factors by recruiting repressors such as \"MeCP2\" which display binding specificity for sequences containing methylated CpG dinucleotides. DNA methylation is controlled by certain methyltransferases, \"DMNTs\", which perform different functions depending on each one. \"DNMT3A\" and \"DNMT3B\" have both been linked to a role in the establishment of DNA methylation pattern in the early development of the stem cell, whereas \"DNMT1\" is required to methylate a newly synthesized strand of DNA after the cell has undergone replication in order to sustain the epigenetic regulatory state. Numerous proteins can physically interact with \"DNMTs\" themselves, which help target \"DNMT1\" to hemi-methylated DNA.",
            "score": 334.5362548828125
        },
        {
            "docid": "9458453_2",
            "document": "DNMT1 . DNA (cytosine-5)-methyltransferase 1 is an enzyme that catalyzes the transfer of methyl groups to specific CpG structures in DNA, a process called DNA methylation. In humans, it is encoded by the \"DNMT1\" gene. DNMT1 forms part of the family of DNA methyltransferase enzymes, which consists primarily of DNMT1, DNMT3A, and DNMT3B.",
            "score": 330.88458251953125
        },
        {
            "docid": "1137227_31",
            "document": "DNA methylation . Maintenance methylation activity is necessary to preserve DNA methylation after every cellular DNA replication cycle. Without the DNA methyltransferase (DNMT), the replication machinery itself would produce daughter strands that are unmethylated and, over time, would lead to passive demethylation. DNMT1 is the proposed maintenance methyltransferase that is responsible for copying DNA methylation patterns to the daughter strands during DNA replication. Mouse models with both copies of DNMT1 deleted are embryonic lethal at approximately day 9, due to the requirement of DNMT1 activity for development in mammalian cells.",
            "score": 324.7681884765625
        },
        {
            "docid": "49033_32",
            "document": "Epigenetics . DNA methylation frequently occurs in repeated sequences, and helps to suppress the expression and mobility of 'transposable elements': Because 5-methylcytosine can be spontaneously deaminated (replacing nitrogen by oxygen) to thymidine, CpG sites are frequently mutated and become rare in the genome, except at CpG islands where they remain unmethylated. Epigenetic changes of this type thus have the potential to direct increased frequencies of permanent genetic mutation. DNA methylation patterns are known to be established and modified in response to environmental factors by a complex interplay of at least three independent DNA methyltransferases, DNMT1, DNMT3A, and DNMT3B, the loss of any of which is lethal in mice. DNMT1 is the most abundant methyltransferase in somatic cells, localizes to replication foci, has a 10\u201340-fold preference for hemimethylated DNA and interacts with the proliferating cell nuclear antigen (PCNA).",
            "score": 322.967529296875
        },
        {
            "docid": "270990_11",
            "document": "DNA methyltransferase . DNMT1 is the most abundant DNA methyltransferase in mammalian cells, and considered to be the key maintenance methyltransferase in mammals. It predominantly methylates hemimethylated CpG di-nucleotides in the mammalian genome. This enzyme is 7\u2013 to 100-fold more active on hemimethylated DNA as compared with unmethylated substrate \"in vitro\", but it is still more active at \"de novo\" methylation than other DNMTs. The recognition motif for the human enzyme involves only three of the bases in the CpG dinucleotide pair: a C on one strand and CpG on the other. This relaxed substrate specificity requirement allows it to methylate unusual structures like DNA slippage intermediates at de novo rates that equal its maintenance rate. Like other DNA cytosine-5 methyltransferases the human enzyme recognizes flipped out cytosines in double stranded DNA and operates by the nucleophilic attack mechanism. In human cancer cells DNMT1 is responsible for both \"de novo\" and maintenance methylation of tumor suppressor genes. The enzyme is about 1,620 amino acids long. The first 1,100 amino acids constitute the regulatory domain of the enzyme, and the remaining residues constitute the catalytic domain. These are joined by Gly-Lys repeats. Both domains are required for the catalytic function of DNMT1.",
            "score": 315.6661071777344
        },
        {
            "docid": "57388876_9",
            "document": "Epigenetics of anxiety and stress-related disorders . DNA methyltransferase 1 (DNMT1) belongs to a family of proteins known as DNA methyltransferases, which are enzymes that add methyl groups to DNA. DNMT1 is specifically involved in maintaining DNA methylation; hence it is also known as the maintenance methylase DNMT1. DNMT1 aids in regulation of gene expression by methylating promoter regions of genes, causing transcriptional repression of these genes.",
            "score": 307.7666931152344
        },
        {
            "docid": "35812169_3",
            "document": "Epigenetics in learning and memory . DNA methylation involves the addition of a methyl group to a 5' cytosine residue. This usually occurs at cytosines that form part of a cytosine-guanine dinucleotide (CpG sites). Methylation can lead to activation or repression of gene transcription and is mediated through the activity of DNA methyltransferases (DNMTs). DNMT3A and DNMT3B regulate \"de novo\" methylation of CpG sites, while DNMT1 maintains established methylation patterns. S-adenosyl methionine acts as the methyl donor.",
            "score": 300.0962219238281
        },
        {
            "docid": "270990_16",
            "document": "DNA methyltransferase . DNMT3a and DNMT3b can mediate methylation-independent gene repression. DNMT3a can co-localize with heterochromatin protein (HP1) and methyl-CpG-binding protein (MeCBP). They can also interact with DNMT1, which might be a co-operative event during DNA methylation. DNMT3a prefers CpG methylation to CpA, CpT, and CpC methylation, though there appears to be some sequence preference of methylation for DNMT3a and DNMT3b. DNMT3a methylates CpG sites at a rate much slower than DNMT1, but greater than DNMT3b.",
            "score": 295.838623046875
        },
        {
            "docid": "53493192_3",
            "document": "GLAD-PCR assay . Method was specially designed to determine methylation of RCGY site of interest in human and mammalian genomes in excess of corresponding unmethylated sites. This is a typical situation for DNA preparations from clinical samples of blood and tissues. GLAD-PCR assay is based on the new type of enzymes - site-specific methyl-directed DNA-endonucleases (MD DNA endonucleases). These enzymes are very similar to restriction enzymes in biochemical properties and cleave DNA completely, but act in opposite way: they cleave only methylated DNA and do not cleave unmethylated DNA at all. Mammalian DNA-methyltransferases DNMT1, DNMT3a and DNMT3b catalyze a reaction of DNA methylation. It is well known that hypermethylation of CpG-islands in regulatory regions of promoter and/or first exon in a variety of genes often occurs at early stages of sporadic carcinogenesis. This leads to downregulation of the genes expression in tumor cells, whereas in a healthy tissue the corresponding genes remain to be active. Thus, the detection of such epigenetic biomarkers is one of the most promising diagnostic and prognostic tools Study of DNMT3a and DNMT3b substrate specificity has shown that both enzymes predominantly recognize RCGY site and modify internal CG-dinucleotide to form 5\u2019-R(5mC)GY-3\u2019/3\u2019-YG(5mC) R-5\u2019 sequence. One of new enzymes GlaI recognizes and cleaves site R(5mC)GY. Due to this unique substrate specificity, GlaI is a convenient tool for identification of \"de novo\" methylated sites in the human and mammalian DNA.GLAD-PCR assay includes 3 simple steps:  Assay is performed in one tube, takes about 2\u20133 hours and determines even several copies of DNA with R(5mC)GY site of interest.",
            "score": 295.2757873535156
        },
        {
            "docid": "35868491_14",
            "document": "Epigenetics in stem-cell differentiation . Several new studies point to the central role of DNA methylation interacting with the regulation of cell cycles and DNA repair pathways in order to maintain the undifferentiated state. In embryonic stem cells, \"DNMT1\" depletion within the undifferentiated progenitor cell compartment led to cell cycle arrest, premature differentiation and a failure of tissue self-renewal. The loss of \"DNMT1\" occurred from profound effects associated with activation of differentiation genes and loss of genes promoting cell cycle progression, thus indicating that \"DNMT1\" and other \"DNMTs\" do not continuously suppress differentiation and thus maintain the pluripotent state.",
            "score": 292.9919738769531
        },
        {
            "docid": "41111089_5",
            "document": "Epigenetic regulation of neurogenesis . DNA methylation's critical nature to corticogenesis has been shown through knockout experiments in mice. When DNMT3b and DNMT1 were ablated separately in mouse embryos they died due to impairment of neural tube development. DNMT3a silencing did not cause embryonic lethality, but did result in a severe detriment in postnatal neurogenesis. This is largely due to the timing in which these epigenetic mechanisms are active. DNMT3b is expressed in early neural progenitor cells and decrease as neural development proceeds and DNMT3a is barely detectable up until embryonic day 10 (E.10). However, at E.10, DNMT3a expression increases significantly from E13.5 and well into adulthood. In the postnatal forebrain, DNMT3a is expressed in the subventricular zone (SVZ) and the hippocampal dentate gyrus, the primary locations for adult neurogenesis. The loss of DNMT3a in post natal neural progenitor cells leads to the down-regulation of neuronic genes such as \"Dlx2\", \"Neurog2\", and \"Sp8\"; but upregulation of genes involved in astroglial and oligodendroglial differentiation, indicating a role in the cell-fate switch from neurogenesis to gliogenesis. DNA demethylation, as well as methylation, of certain genes allows for neurogenesis to proceed in a time dependent manner. One such gene is \"Hes5\", hypermethylated in E7.5 Embryos but completely demethylated by E9.5, which is one of the target genes in the Notch Signaling pathway. GCM1 and GCM2 demethylate the \"Hes5\" promoter, allowing it to respond to NOTCH signaling and initiating the generation of neural stem cells. Another example is the \"Gfap\" gene which is required for astrocyte differentiation. The ability to differentiate into glial cells is repressed in neural stem cells with a neuronal cell fate. This repression is due largely to an irresponsiveness of neural stem cells towards astrocyte-inducing stimulations. The neural stem cells are non-responsive due to hypermethylated DNA in the promoter regions of astrocyte genes such as \"Gfap\". The STAT3 binding site in the promoter region of \"Gfap\" is hypermethylated at E11.5 and barely so at E14.5, at which point it is able to receive astrocyte inducing stimulations and begin cytokine-inducible astrocyte differentiation.",
            "score": 291.33709716796875
        },
        {
            "docid": "1137227_33",
            "document": "DNA methylation . Since many tumor suppressor genes are silenced by DNA methylation during carcinogenesis, there have been attempts to re-express these genes by inhibiting the DNMTs. 5-Aza-2'-deoxycytidine (decitabine) is a nucleoside analog that inhibits DNMTs by trapping them in a covalent complex on DNA by preventing the \u03b2-elimination step of catalysis, thus resulting in the enzymes' degradation. However, for decitabine to be active, it must be incorporated into the genome of the cell, which can cause mutations in the daughter cells if the cell does not die. In addition, decitabine is toxic to the bone marrow, which limits the size of its therapeutic window. These pitfalls have led to the development of antisense RNA therapies that target the DNMTs by degrading their mRNAs and preventing their translation. However, it is currently unclear whether targeting DNMT1 alone is sufficient to reactivate tumor suppressor genes silenced by DNA methylation.",
            "score": 289.9020080566406
        },
        {
            "docid": "5065725_11",
            "document": "Methyltransferase . DNA methylation, a key component of genetic regulation, occurs primarily at the 5-carbon of the base cytosine, forming 5\u2019methylcytosine (see left). Methylation is an epigenetic modification catalyzed by DNA methyltransferase enzymes, including DNMT1, DNMT2, and DNMT3. These enzymes use S-adenosylmethionine as a methyl donor and contain several highly conserved structural features between the three forms; these include the S-adenosylmethionine binding site, a vicinal proline-cysteine pair which forms a thiolate anion important for the reaction mechanism, and the cytosine substrate binding pocket. Many features of DNA methyltransferases are highly conserved throughout many classes of life, from bacteria to mammals. In addition to controlling the expression of certain genes, there are a variety of protein complexes, many with implications for human health, which only bind to methylated DNA recognition sites. Many of the early DNA methyltransferases have been thought to be derived from RNA methyltransferases that were supposed to be active in the RNA world to protect many species of primitive RNA. RNA methylation has been observed in different types of RNA species viz.mRNA, rRNA, tRNA, snoRNA, snRNA, miRNA, tmRNA as well as viral RNA species. Specific RNA methyltransferases are employed by cells to mark these on the RNA species according to the need and environment prevailing around the cells, which form a part of field called molecular epigenetics. 2'-O-methylation, m6A methylation, m1G methylation as well as m5C are most commonly methylation marks observed in different types of RNA.",
            "score": 289.3173828125
        },
        {
            "docid": "14170781_3",
            "document": "DNA (cytosine-5)-methyltransferase 3A . This enzyme is responsible for \"de novo\" DNA methylation. Such function is to be distinguished from maintenance DNA methylation which ensures the fidelity of replication of inherited epigenetic patterns. DNMT3A forms part of the family of DNA methyltransferase enzymes, which consists of the protagonists DNMT1, DNMT3A and DNMT3B.",
            "score": 288.81231689453125
        },
        {
            "docid": "209459_31",
            "document": "Alternative splicing . One example of a specific splicing variant associated with cancers is in one of the human DNMT genes. Three DNMT genes encode enzymes that add methyl groups to DNA, a modification that often has regulatory effects. Several abnormally spliced DNMT3B mRNAs are found in tumors and cancer cell lines. In two separate studies, expression of two of these abnormally spliced mRNAs in mammalian cells caused changes in the DNA methylation patterns in those cells. Cells with one of the abnormal mRNAs also grew twice as fast as control cells, indicating a direct contribution to tumor development by this product.",
            "score": 286.3365478515625
        },
        {
            "docid": "1137227_14",
            "document": "DNA methylation . Whereas DNA methylation is not necessary \"per se\" for transcriptional silencing, it is thought nonetheless to represent a \u201clocked\u201d state that definitely inactivates transcription. In particular, DNA methylation appears critical for the maintenance of mono-allelic silencing in the context of genomic imprinting and X chromosome inactivation. In these cases, expressed and silent alleles differ by their methylation status, and loss of DNA methylation results in loss of imprinting and re-expression of Xist in somatic cells. During embryonic development, few genes change their methylation status, at the important exception of many genes specifically expressed in the germline. DNA methylation appears absolutely required in differentiated cells, as knockout of any of the three competent DNA methyltransferase results in embryonic or post-partum lethality. By contrast, DNA methylation is dispensable in undifferentiated cell types, such as the inner cell mass of the blastocyst, primordial germ cells or embryonic stem cells. Since DNA methylation appears to directly regulate only a limited number of genes, how precisely DNA methylation absence causes the death of differentiated cells remain an open question.",
            "score": 283.6510009765625
        },
        {
            "docid": "270990_13",
            "document": "DNA methyltransferase . DNMT1 null mutant embryonic stem cells were viable and contained a small percentage of methylated DNA and methyltransferase activity. Mouse embryos homozygous for a deletion in Dnmt1 die at 10\u201311 days gestation.",
            "score": 283.3543395996094
        },
        {
            "docid": "8309061_7",
            "document": "Decitabine . It incorporates into DNA strands upon replication, and then when DNA methyltransferases (DNMTs) such as DNMT1, are engaged to bind the DNA and to replicate the methylation to the daughter strand, DNMTs are bound to decitabine irreversibly and cannot disengage. Therefore, the action of decitabine is division-dependant, meaning the cells have to divide in order for the pharmaceutical to act. Therefore, cancer cells which divide much more rapidly than most other cells in the body will be more severely affected by decitabine just because they replicate more. In cancer cells, and more specifically in haematological malignancies, it seems that DNA hypermethylation is really critical for their development. Methylation of CpG islands upstream of tumor suppressor genes in order to silence them seems to be critical for these type of cancers. Thus at optimal doses, decitabine is blocking this type of methylation and has an anti-neoplastic effect.",
            "score": 282.71063232421875
        },
        {
            "docid": "9458453_4",
            "document": "DNMT1 . DNMT1 has been shown to interact with UHRF1,: DNMT1 is highly transcribed during the S phase of the cell cycle when it is required for methylation of the newly generated hemimethylated sites on daughter DNA strands. Its interaction with PCNA and UHRF1 has been implicated in localizing it to the replication fork. The direct co-operation between DNMT1 and G9a coordinates DNA and H3K9 methylation during cell division. This chromatin methylation is necessary for stable repression of gene expression during mammalian development.",
            "score": 282.0191955566406
        },
        {
            "docid": "52237542_17",
            "document": "DNA methylation in cancer . Some miRNAs target the messenger RNAs for DNA methyltransferase genes \"DNMT1\", \"DNMT3A\" and \"DNMT3B\", whose gene products are needed for initiating and stabilizing promoter methylations. As summarized in three reviews, miRNAs miR-29a, miR-29b and miR-29c target DNMT3A and DNMT3B; miR-148a and miR-148b target DNMT3B; and miR-152 and miR-301 target DNMT1. In addition, miR-34b targets DNMT1 and the promoter of miR-34b itself is hypermethylated and under-expressed in the majority of prostate cancers. When expression of these microRNAs is altered, they may also be a source of the hyper/hypo-methylation of the promoters of protein-coding genes in cancers.",
            "score": 279.71832275390625
        },
        {
            "docid": "51304858_5",
            "document": "Neuroepigenetics . Other studies showed a trend for DNMT3a and DNMT3b. However, these DNMT's add new methyl marks on unmethylated DNA, unlike DNMT1. Like DNMT1, the loss of DNMT3a and 3b resulted in neuromuscular degeneration two months after birth, as well as poor survival rates amongst the progeny of the mutant cells, even though DNMT3a does not regularly function to maintain methylation marks. This conundrum was addressed by other studies which recorded rare loci in mature neurons where DNMT3a acted as a maintenance DNMT. The Gfap locus, which codes for the formation and regulation of the cytoskeleton of astrocytes, is one such locus where this activity is observed. The gene is regularly methylated to downregulate glioma related cancers. DNMT inhibition leads to decreased methylation and increased synaptic activity. Several studies show that the methylation-related increase or decrease in synaptic activity occurs due to the upregulation or downregulation of receptors at the neurological synapse. Such receptor regulation plays a major role in many important mechanisms, such as the 'fight or flight' response. The glucocorticoid receptor (GR) is the most studied of these receptors. During stressful circumstances, there is a signaling cascade that begins from the pituitary gland and terminates due to a negative feedback loop from the adrenal gland. In this loop, the increase in the levels of the stress response hormone results in the increase of GR. Increase in GR results in the decrease of cellular response to the hormone levels. It has been shown that methylation of the I7 exon within the GR locus leads to a lower level of basal GR expression in mice. These mice were more susceptible to high levels of stress as opposed to mice with lower levels of methylation at the I7 exon. Up-regulation or down-regulation of receptors through methylation leads to change in synaptic activity of the neuron.",
            "score": 279.42279052734375
        },
        {
            "docid": "51304858_4",
            "document": "Neuroepigenetics . DNA methyltransferases (DNMTs) are involved in regulation of the electrophysiological landscape of the brain through methylation of CpGs. Several studies have shown that inhibition or depletion of DNMT1 activity during neural maturation leads to hypomethylation of the neurons by removing the cell's ability to maintain methylation marks in the chromatin. This gradual loss of methylation marks leads to changes in the expression of crucial developmental genes that may be dosage sensitive, leading to neural degeneration. This was observed in the mature neurons in the dorsal portion of the mouse prosencephalon, where there was significantly greater amounts of neural degeneration and poor neural signaling in the absence of DNMT1. Despite poor survival rates amongst the DNMT1-depleted neurons, some of the cells persisted throughout the lifespan of the organism. The surviving cells reaffirmed that the loss of DNMT1 led to hypomethylation in the neural cell genome. These cells also exhibited poor neural functioning. In fact, a global loss of neural functioning was also observed in these model organisms, with the greatest amounts neural degeneration occurring in the prosencephalon.",
            "score": 277.499755859375
        },
        {
            "docid": "57386068_9",
            "document": "Epigenetic effects of smoking . This binding leads to an increase in calcium levels which in turn can activate the cAMP response element-binding protein (CREB) transcription factor. The most striking downstream effect of the upregulation of this transcription factor is the downregulation of the DNMT1 gene, which has a cAMP response element in its promoter. This down-regulation of DNMT1 can have serious consequences on DNA methylation, namely a failure to maintain normal methylation patterns during DNA replication and repair. The upregulation of DNMT3b has also been shown to occur as a result of cigarette exposure.",
            "score": 274.3706359863281
        },
        {
            "docid": "42684750_6",
            "document": "Contribution of epigenetic modifications to evolution . A comparative analysis of CpG methylation patterns between humans and primates found that there were more than 800 genes that varied in their methylation patterns among orangutans, gorillas, chimpanzees, and bonobos. Despite these apes having the same genes, methylation differences are what account for their phenotypic variation. The genes in question are involved in development. It is not the protein sequences that account for the differences in physical characteristics between humans and apes; rather, it is the epigenetic changes to the genes. Since humans and the great apes share 99% of their DNA, it is thought that the differences in methylation patterns account for their distinction. So far, there are known to be 171 genes that are uniquely methylated in humans, 101 genes that are uniquely methylated in chimpanzees and bonobos, 101 genes that are uniquely methylated in gorillas, and 450 genes that are uniquely methylated in orangutans. For example, genes involved in blood pressure regulation and the development of the inner ear\u2019s semicircular canal are highly methylated in humans, but not in the apes. There are also 184 genes that are conserved at the protein level between human and chimpanzees, but have epigenetic differences. Enrichments in multiple independent gene categories show that regulatory changes to these genes have given humans their specific traits. This research shows that epigenetics plays an important role in evolution in primates. It has also been shown that cis-regulatory elements changes affect the transcription start sites (TSS) of genes. 471 DNA sequences are found to be enriched or depleted in regards to histone trimethylation at the H3K4 histone in chimpanzee, human, and macaque prefrontal cortexes. Among these sequences, 33 are selectively methylated in neuronal chromatin from children and adults, but not from non-neuronal chromatin. One locus that was selectively methylated was DPP10, a regulatory sequence that showed evidence of hominid adaptation, such as higher nucleotide substitution rates and certain regulatory sequences that were missing in other primates. Epigenetic regulation of TSS chromatin has been identified as an important development in the evolution of gene expression networks in the human brain. These networks are thought to play a role in cognitive processes and neurological disorders. An analysis of methylation profiles of humans and primate sperm cells reveals epigenetic regulation plays an important role here as well. Since mammalian cells undergo reprogramming of DNA methylation patterns during germ cell development, the methylomes of human and chimp sperm can be compared to methylation in embryonic stem cells (ESCs). There were many hypomethylated regions in both sperms cells and ESCs that showed structural differences. Also, many of the promoters in human and chimp sperm cells had different amounts of methylation. In essence, DNA methylation patterns differ between germ cells and somatic cells as well as between the human and chimpanzee sperm cells. Meaning, differences in promoter methylation could possible account for the phenotypic differences between humans and primates.",
            "score": 273.6105041503906
        },
        {
            "docid": "42663845_7",
            "document": "Epigenetics of physical exercise . Epigenetic mechanisms affected by physical exercise have also been seen to be involved in age-related processes. A major component of aging is significant loss of DNA methylation over time. Methyl deoxycytidine, which is a methylated cytosine on the 5\u2019 carbon of a cytosine, is involved in the process of cell differentiation and maintenance. Cell differentiation involves methylation of different areas within the DNA of a cell, which can alter the transcription of genes. During cell differentiation, DNA methylation is important for establishing the identity and function of a cell because of its role in controlling gene expression. A recent study looking at genome DNA methylation of newborn infants and humans aged 100 years or older found that the older individuals had significantly decreased overall DNA methylation. As one ages, the amount of DNA methylation slowly begins to decrease.",
            "score": 273.5260314941406
        },
        {
            "docid": "42683705_4",
            "document": "Epigenetics and melanoma . In epigenetic alterations in cancer, DNA methylation is the most studied, although it is not the only alteration that can occur. DNA methylation is a covalent modification of DNA where a methyl group is added to the C-5 position of cytosine by DNA-methyltransferases. This occurs mostly at the cytosine-phosphate-guanine dinucleotide rich regions, known as CpG islands, and are located particularly in the promoter regions of genes in the human genome (Patino et al. 2008). These promoter regions are methylated in certain ways or can be completely unmethylated. However, in an altered methylation of the CpG islands (generally where the methylation pattern is inverted), transcription can be altered which can lead to cancer. This is due to chromosomes being highly condensed, preventing RNA polymerase and other transcription factors from recognizing and binding to the DNA. This can result in gene silencing. This silencing of genes can be dangerous to cells, especially when the genes silenced are active in maintaining the cell cycle. The table below shows some of the important genes targeted by promoter hypermethylation in melanoma.",
            "score": 272.1779479980469
        },
        {
            "docid": "17062920_39",
            "document": "DNA damage theory of aging . Several reviews summarize evidence that the methylation enzyme DNMT1 is recruited to sites of oxidative DNA damage. Recruitment of DNMT1 leads to DNA methylation at the promoters of genes to inhibit transcription during repair. In addition, the 2018 review describes recruitment of DNMT1 during repair of DNA double-strand breaks. DNMT1 localization results in increased DNA methylation near the site of recombinational repair, associated with altered expression of the repaired gene. In general, repair-associated hyper-methylated promoters are restored to their former methylation level after DNA repair is complete. However, these reviews also indicate that transient recruitment of epigenetic modifiers can occasionally result in subsequent stable epigenetic alterations and gene silencing after DNA repair has been completed.",
            "score": 272.0512390136719
        },
        {
            "docid": "9955145_31",
            "document": "Eukaryotic transcription . The gene expression patterns that define cell identity are inherited through cell division. This process is called epigenetic regulation. DNA methylation is reliably inherited through the action of maintenance methylases that modify the nascent DNA strand generated by replication. In mammalian cells, DNA methylation is the primary marker of transcriptionally silenced regions. Specialized proteins can recognize the marker and recruit histone deacetylases and methylases to re-establish the silencing. Nucleosome histone modifications could also be inherited during cell division, however, it is not clear whether it can work independently without the direction by DNA methylation.",
            "score": 270.6552429199219
        },
        {
            "docid": "343457_20",
            "document": "Maternal effect . Related to adaptive maternal effects are epigenetic effects. Epigenetics is the study of long lasting changes in gene expression that are produced by modifications to chromatin instead of changes in DNA sequence, as is seen in DNA mutation. This \"change\" refers to DNA methylation, histone acetylation, or the interaction of non-coding RNAs with DNA. DNA methylation is the addition of methyl groups to the DNA. When DNA is methylated in mammals, the transcription of the gene at that location is turned down or turned off entirely. The induction of DNA methylation is highly influenced by the maternal environment. Some maternal environments can lead to a higher methylation of an offspring's DNA, while others lower methylation.[22] The fact that methylation can be influenced by the maternal environment, makes it similar to adaptive maternal effects. Further similarities are seen by the fact that methylation can often increase the fitness of the offspring. Additionally, epigenetics can refer to histone modifications or non-coding RNAs that create a sort of cellular memory. Cellular memory refers to a cell's ability to pass nongenetic information to its daughter cell during replication. For example, after differentiation, a liver cell performs different functions than a brain cell; cellular memory allows these cells to \"remember\" what functions they are supposed to perform after replication. Some of these epigenetic changes can be passed down to future generations, while others are reversible within a particular individual's lifetime. This can explain why individuals with identical DNA can differ in their susceptibility to certain chronic diseases.",
            "score": 265.2701416015625
        },
        {
            "docid": "1137227_35",
            "document": "DNA methylation . The principal \"Arabidopsis\" DNA methyltransferase enzymes, which transfer and covalently attach methyl groups onto DNA, are DRM2, MET1, and CMT3. Both the DRM2 and MET1 proteins share significant homology to the mammalian methyltransferases DNMT3 and DNMT1, respectively, whereas the CMT3 protein is unique to the plant kingdom. There are currently two classes of DNA methyltransferases: 1) the \"de novo\" class, or enzymes that create new methylation marks on the DNA; and 2) a maintenance class that recognizes the methylation marks on the parental strand of DNA and transfers new methylation to the daughters strands after DNA replication. DRM2 is the only enzyme that has been implicated as a \"de novo\" DNA methyltransferase. DRM2 has also been shown, along with MET1 and CMT3 to be involved in maintaining methylation marks through DNA replication. Other DNA methyltransferases are expressed in plants but have no known function (see the Chromatin Database).",
            "score": 260.1001892089844
        }
    ]
}